Hirosha K Jayaweera1, Jim Lagopoulos2, Shantel L Duffy3, Simon J G Lewis1, Daniel F Hermens2, Louisa Norrie1, Ian B Hickie1, Sharon L Naismith4. 1. Healthy Brain Ageing Program, Brain & Mind Research Institute, University of Sydney NSW Australia; Clinical Research Unit, Brain & Mind Research Institute, University of Sydney NSW Australia. 2. Clinical Research Unit, Brain & Mind Research Institute, University of Sydney NSW Australia. 3. Healthy Brain Ageing Program, Brain & Mind Research Institute, University of Sydney NSW Australia; Clinical Research Unit, Brain & Mind Research Institute, University of Sydney NSW Australia; School of Psychology, University of Sydney NSW Australia. 4. Healthy Brain Ageing Program, Brain & Mind Research Institute, University of Sydney NSW Australia; Clinical Research Unit, Brain & Mind Research Institute, University of Sydney NSW Australia; School of Psychology, University of Sydney NSW Australia. Electronic address: sharon.naismith@sydney.edu.au.
Abstract
BACKGROUND: Glutamate (Glu) and N-acetyl aspartate (NAA) are markers of excitatory processes and neuronal compromise respectively. Increased Glu and decreased NAA concentrations have been implicated in the pathophysiology of depression and cognitive impairment respectively. OBJECTIVE: To determine the relationship between NAA, Glu, memory and key clinical features in older people with lifetime depression compared to comparison subjects. METHOD: Thirty-five health-seeking older adults (mean age=63.57 years), with a lifetime depression diagnosis, and 21 age-matched healthy comparison subjects (mean age=65.48 years) underwent neuropsychological testing, psychiatric assessment and proton magnetic resonance spectroscopy from which Glu and NAA were measured (reported as a ratio to creatine). RESULTS: Compared to comparison subjects, the depressed subjects showed poorer verbal learning and memory retention. Hippocampal NAA and Glu did not differ significantly between groups. However, in comparison subjects, lower levels of hippocampal Glu were associated with poorer memory retention (r=0.55, p=0.018). In the depressed subjects, lower levels of hippocampal NAA were related to poorer verbal learning (r=0.44, p=0.008) and memory retention (r=0.41, p=0.018). Greater hippocampal Glu was associated with more severe depressive symptoms (r=0.35, p=0.039) and an earlier age of illness onset (r=-0.37, p=0.031). LIMITATIONS: This is a cross sectional study with a heterogeneous group of depressed subjects. CONCLUSION: Our findings highlight that hippocampal neurometabolites are entwined with both clinical and cognitive features associated with depression in older adults and further suggest that differential mechanisms may underpin these features.
BACKGROUND:Glutamate (Glu) and N-acetyl aspartate (NAA) are markers of excitatory processes and neuronal compromise respectively. Increased Glu and decreased NAA concentrations have been implicated in the pathophysiology of depression and cognitive impairment respectively. OBJECTIVE: To determine the relationship between NAA, Glu, memory and key clinical features in older people with lifetime depression compared to comparison subjects. METHOD: Thirty-five health-seeking older adults (mean age=63.57 years), with a lifetime depression diagnosis, and 21 age-matched healthy comparison subjects (mean age=65.48 years) underwent neuropsychological testing, psychiatric assessment and proton magnetic resonance spectroscopy from which Glu and NAA were measured (reported as a ratio to creatine). RESULTS: Compared to comparison subjects, the depressed subjects showed poorer verbal learning and memory retention. Hippocampal NAA and Glu did not differ significantly between groups. However, in comparison subjects, lower levels of hippocampal Glu were associated with poorer memory retention (r=0.55, p=0.018). In the depressed subjects, lower levels of hippocampal NAA were related to poorer verbal learning (r=0.44, p=0.008) and memory retention (r=0.41, p=0.018). Greater hippocampal Glu was associated with more severe depressive symptoms (r=0.35, p=0.039) and an earlier age of illness onset (r=-0.37, p=0.031). LIMITATIONS: This is a cross sectional study with a heterogeneous group of depressed subjects. CONCLUSION: Our findings highlight that hippocampal neurometabolites are entwined with both clinical and cognitive features associated with depression in older adults and further suggest that differential mechanisms may underpin these features.
Authors: C Woolf; A Lampit; Z Shahnawaz; J Sabates; L M Norrie; D Burke; S L Naismith; L Mowszowski Journal: Neuropsychol Rev Date: 2021-04-28 Impact factor: 7.444
Authors: Gwenn S Smith; Georg Oeltzschner; Neda F Gould; Jeannie-Marie S Leoutsakos; Najilla Nassery; Jin Hui Joo; Michael A Kraut; Richard A E Edden; Peter B Barker; S Andrea Wijtenburg; Laura M Rowland; Clifford I Workman Journal: J Affect Disord Date: 2020-10-07 Impact factor: 4.839